GlassScriptPhysician profile
Ofelia Portillo
NPI 1568915536
$556.84
in general payments reported to CMS, 2019-2025
11 companies · $93.10 in 2025
The $93.10 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.90 · 2022: $163 · 2023: $141 · 2024: $108 · 2025: $93.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $141.96 | 2022 | |
| Penumbra, INC. | $101.00 | 2023-2025 | Penumbra System, Pod, Penumbra Coil 400 |
| Microvention, INC. | $73.50 | 2024 | Web Aneurysm Embolization System, Stent, Hydrosoft Advanced |
| Depuy Synthes Sales INC. | $51.90 | 2021 | |
| Novartis Pharmaceuticals Corporation | $46.05 | 2022-2023 | |
| Qapel Medical INC | $44.41 | 2023 | |
| Lundbeck LLC | $29.33 | 2025 | Vyepti |
| Ucb, INC. | $17.78 | 2025 | Briviact |
| Pfizer INC. | $17.13 | 2024 | |
| Neurelis, INC. | $17.04 | 2024 | Valtoco |
| Chiesi USA, INC. | $16.74 | 2023 | Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ofelia Portillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.